SCHEMBL20670367

SCHEMBL20670367

CCOC(=O)C1=C(CC)CN(Cc2ccccc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.52
CHRM2 P08172 1/20 0.48
CHRM4 P08173 1/20 0.48
CHRM5 P08912 1/20 0.48
CHRM1 P11229 1/20 0.48
CHRM3 P20309 1/20 0.48
LMNA P02545 4/20 0.47
MEN1 O00255 3/20 0.47
MAPT P10636 3/20 0.47
KMT2A Q03164 3/20 0.47
ADORA1 P30542 1/20 0.47
MAPK1 P28482 3/20 0.47
TSHR P16473 2/20 0.47
PRMT1 Q99873 1/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
TRPC5 Q9UL62 1/20 0.44
POLB P06746 1/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15415970 0.86 CASP3 (0.54) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL7917885 0.84 LMNA (0.53) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL22667121 0.84 CHRM5 (0.47) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL1752279 0.83 CHRM5 (0.62) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL29992308 0.81 CASP3 (0.49) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL26342105 0.79 CHRM5 (0.47) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL2274453 0.79 CASP3 (0.47) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL18740324 0.78 KMT2A (0.47) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL15420762 0.78 MEN1 (0.61) CASP3CHRM2CHRM4CHRM5CHRM1
SCHEMBL20300563 0.77 MEN1 (0.57) CASP3CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163409-A1 ALTERNATE PROCESSES FOR THE PREPARATION OF PYRROLIDINE DERIVATIVES Dr Reddys Laboratories Ltd (IN) 2021-06-03 US disclosed
US-20210163409-A1 ALTERNATE PROCESSES FOR THE PREPARATION OF PYRROLIDINE DERIVATIVES Dr Reddys Laboratories Ltd (IN) 2021-06-03 US disclosed
WO-2019016745-A1 ALTERNATE PROCESSES FOR THE PREPARATION OF PYRROLIDINE DERIVATIVES DR. REDDY'S LABORATORIES LIMITED (IN) 2019-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163409-A1 ALTERNATE PROCESSES FOR THE PREPARATION OF PYRROLIDINE DERIVATIVES PRKD1, JAK1, JAK3 CASP3 1916/4885CHRM2 4786/4885CHRM4 4491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.